Avalo Therapeutics Inc. – Filings and Transcripts

NASDAQ: AVTX
Share price (6/2/26): $13.96
Market cap (6/2/26): $734 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Registration of securities for employees

Ownership Filter

Goldman Jonathan

Deep Track Capital, LP

News Filter

Reports First Quarter 2026 Financial Results and Recent Business Updates

Material Definitive Agreement, Earnings Release or Operating Update, Material Disclosure, Financial Statements or Exhibits

Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Purchases Optional Milestone Buyout

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Scanned paper annual report submission

Letter from the SEC

Notice of effectiveness